Stocksigma LogoStocksigma Logo

Mukka Proteins Board Meeting Scheduled for 7th Nov'26 to Consider Q2 Results

Mukka Proteins Limited has scheduled a Board of Directors meeting on 7th Nov'26 to consider and approve the standalone and consolidated unaudited financial

Mukka Proteins Board Meeting Scheduled for 7th Nov'26 to Consider Q2 Results

Mukka Proteins Ltd 路 Intimation 路 07 Nov 2026, 5:30 am

Mukka Proteins Board Meeting Scheduled for 7th Nov'26 to Consider Q2 Results Mukka Proteins Limited has scheduled a Board of Directors meeting on 7th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI Insider Trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will remain closed until 48 hours following the declaration of the financial results for designated persons and their immediate relatives.

Original exchange filing (PDF)

More announcements from Mukka Proteins Ltd

All Mukka Proteins Ltd announcements